Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
Breakthroughs begin here. At the Inaugural Charles River World Congress on Animal Models in Drug Discovery & Development, industry leaders will convene to discuss reverse translational medicine. Read More
Join Charles River and the Gartner/CEB R&D Leadership Council for a full day of facilitated discussion about fostering innovation to ensure clients are provided with the most efficient path to market. Read More
Today the USPTO issued a patent to MA biotech start-up company Asymmetrex for the first technology able to count and evaluate previously elusive adult tissue stem cells. Read More
Two clinical trials investigating CNTX-4975 for the treatment of pain associated with Morton’s neuroma, for which it has received both Orphan Drug and Fast Track designation fr Read More
AstraZeneca is reinvesting a further A$100 million to expand its manufacturing facility in North Ryde, Sydney. Read More
Agilis Biotherapeutics, a biotechnology company advancing innovative DNA therapeutics for rare genetic diseases that affect the central nervous system, announce a joint venture with GTRI. Read More
Wilmington, Del. – July 31, 2017—HealthCore, Inc., a health outcomes research company, has hired Ehab Hasan – a leader in pharmaceutical research – as head of late phase operations to execute strategi Read More